Damartex SA (FR:ALDAR) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Damartex SA reported a decrease in annual revenue to €529.2 million, a 9.9% drop, amid challenging economic conditions, while achieving a significant improvement in operational EBITDA to €9.6 million, up by 120.7%. The ‘Fashion’ division faced a revenue decline but showed strong performances in the Xandres brand, whereas the ‘Healthcare’ division plans to reorganize due to underperforming catalog sales. Despite these efforts, the company recorded a net loss of €36.0 million for the financial year, largely due to non-recurring events and restructuring costs.
For further insights into FR:ALDAR stock, check out TipRanks’ Stock Analysis page.